ÀÏ×ÓÓÐÇ®lzyq88¹ÙÍø

À´Ô´£º½ø¿ÚÄÐÈËÓÃÆ· £¬×÷Õߣº ÌåÓýÔ˶¯ £¬£º

ุúÄ㽲࣠£¬¹ðÁÖ³ÇÀïÍ·ÄÇЩÀϵط½ £¬½²Õæ £¬ÕæÊÇÔ½°áÔ½ÈÃÈËÕÒ²»×ű±ÁË¡£¾ÍÏñ֮ǰµÄÀ³É½Îç̨СÏï×Ó £¬Ïëµ±ÄêßÖ £¬ÄÇÀï³ÔµÄºÈµÄ¼òÖ±ÊÇˬµ½ÂѶ¼µø¡£ºÃ¶àÈËÌØµØ´Ó±ð¸öµØ·½ÅÜÀ´ £¬¾ÍΪÁ˳¢³¢Õý×ڵĹðÁÖζµÀ¡£°¥Ó´ £¬ÏÖÔÚÌý½²°áÁË £¬¸ãµÃÈ˶¼ÔÚÎÊ£º¾¿¾¹°áµ½ÄÄ¿­È¥ÁË£¿ÏÂÃæßÖ £¬ÎҺúøúÄã´µÒ»ÂÖ £¬¿´ÄãÏþµÃûÄÇЩÄÚÄ»ÏûÏ¢ßÖ¡£

À³É½Îç̨СÏï×ÓÒÔǰÊǸö¸£µØ £¬°¤ÂÑÃÍ£¡

ÏȽ²¸ö࣠£¬ÒÔǰÄǸöСÏï×ÓÀïÍ·°¡ £¬ÕæµÄÊÇɶ¶¼ÓС£Ã×·ÛµêßÖ £¬Â±Î¶Ì¯ßÖ £¬ÉÕ¿¾Ì¯ßÖ £¬Á¬ÂôÌÇÓÍôÎôεÄÀϰ¢ÆÅ¶¼ÔÚÄDZßÔúÁ˸ù¡£È˼Ò˵³Ô»õµÄÌìÌà £¬ÂÑû´í£¡ÌرðÊÇÄǸöÒ¹ÊÐ £¬¶ªÄÇÐÇ £¬²îµãûÅŶÓÅŵ½·èÁË¡£Óиã¸öÃ×·Û̯×Ó £¬Â±Ë®ÏãµÃÂÑë¶¼µß £¬³ÔÒ»¿ÚÄã¾ÍÏþµÃΪʲôÄÇô¶àÈËÉá²»µÃÀ뿪¡£

Ïà¹ØÍ¼Æ¬

²»¹ýßÖ £¬ØÊºóÌý½²ÊÇÒòΪҪ¸ïР£¬¸ãµÃÕû¸öÏï×Ó¶¼²ðÁË¡£ÄÇЩÀϰåÒ²ÊÇ £¬Ã»µÃ²½·¥ £¬Ö»Äܰá×ß¡£½²ÆðÕâ¸öÊÂ࣠£¬ÕæÊÇÓеãÐÄÍ´ £¬ÏñÊǰÇÀô¬Ò»Ñù £¬¸ãµÃÒ»µØ¼¦Ã« £¬³Ô»õÃǶ¼¿ÞÁË¡£¶Ô²î³Øà££¿Äã½²ÊDz»ÊǸü×Ó£¿

ÏÖÔÚ°áµ½ÄÄ¿­È¥ÁË£¿Äã¸ãÂÑû¼û£¿

ÎÒ¹À¶ÑÓ´ £¬Ðí¶àÈ˶¼ÔÚÎÊÕâ¸öÎÊÌâ¡£ÄãÏþµÃû £¬ÏÖÔÚÄÇЩÀϰåÃÇËÆºõÊǰᵽÏóÉ½ÇøÄÇÒ»´øÈ¥ÁË £¬¾ßÌåλÖÃÂï £¬Ìý½²ÊÇÔÚÆßÐÇ·ËÄÖܵÄпªÉÌÒµ½Ö¡£Äã¿ËÄÇÀïתһȦ £¬Óи㼸¸öÀÏÊìÈËÔÚÄÇ £¬»¹ÄܳԵ½ÒÔǰµÄζµÀ £¬ÂѺúȵÄÃ×·ÛÕÕ¾ÉÓÐ £¬Â±Î¶Ò²ÊÇÇõð¸Ü £¬Äã¿ÉÒÔÊÔÏÂ×Ó¡£

ÐÑÁúµã£º¿ËÆßÐÇÄDZß×îºÃÂéÖ±×ßµ½ºóÃæµÄÏï×Ó £¬Ã»È»ÂÑÕÒ²»µ½¡£Òª²»È»»¹ÒÔΪÄÇЩÀϰ嶼ûÂÑÀí¿ªµêÁË¡£

Äܲ»¿É³Ôµ½ÒÔǰÄÇÖÖζµÀßÖ£¿ÂÑÊǵģ¡

ุúÄ㽲࣠£¬Î¶µÀÕÕ¾ÉÓеã·×ÆçÑùµÄ¡£ËäÈ»ÄÇЩÀÏ°å´ø×Å×Ô¼ºµÄÊÖÒպ͹øÍëÆ°ÅèÈ¥ÁËеط½ £¬µ«È˼ҽ²Çé¿ö·×ÆçÑùÁË £¬¸ÐÊÜÒ²»á±äµÃÓеã²î³ØÍ·¡£²»¹ýßÖ £¬ÂÑÊǵÄ £¬Ã×·ÛÕÕ¾ÉÃ×·Û £¬Â±Ë®Õվɱˮ £¬³ÔÆðÕÕ¾ÉÓÐÄÇÖÖÊìϤµÄζµÀ¡£¾¿¾¹ÊÇÀϹðÁÖµÄζµÀ £¬ËãÂÑÃÍÁË £¬ÖµµÃ¿ËÊÔÏÂ×Ó¡£

²»¹ýÎÒÌý½² £¬ÓÐЩÀϰ廹Ïë»ØÀ´Ô­µØ¿ªµê £¬µ«µØ·½³Ù³Ùû¸ãºÃ¡£ÕæµÄÊǸãÂÑû¼û £¬À˲ÙÐÄÇ飡²»¹ýÄãÒ²±ð¼± £¬µÈ¹ýÒ»¶Îʱ¼ä £¬¿ÉÄÜ»áÓÐÐÂÏûÏ¢¡£½²µ½ÕâÀïßÖ £¬ÄãÒªÊÇʵÔÚ²öÁË £¬¸Ïæ¿ËÆßÐÇÄDZßÕһصãζµÀ°É¡£


Ïà¹ØÍ¼Æ¬

ÄǾ¿¾¹À³É½Îç̨СÏï×ÓµÄÀϰåÃǰáÄÄ¿­È¥ÁË£¿ÂÑÓö¼Ã»£¡Äã¾Í¼Ç×ÅÒ»µã£ºÆßÐÇ·ËÄÖÜпªÉÌÒµ½Ö £¬¼°Ôç¿Ë £¬±ð¸ãÂÑû¼û¡£

À³É½Îç̨СÏï×Ó, ¹ðÁÖÃÀʳ, Àϵط½°á¼Ò, ÆßÐÇ·ÃÀʳ, ¹ðÁÖÌØÉ«

Ïà¹ØÍ¼Æ¬

¡¶º£¿ÚÄĸöÏï×ÓÓÐÅ®ÈË¡·

¡°×÷ΪÐÐÒµÊ׸öÐÔÄÜUltra £¬ÕâÊÇÎÒÃÇÀúʱ7ÄêΪËûÃÇÁ¿Éí´òÔìµÄáÛ·åÖ®×÷ £¬Ëü²»Êǵü´ú £¬Ô½·¢²»ÊÇÉý¼¶ £¬¶øÊÇÖØ¹¹£¡ÎÒÃÇÖØ¹¹ÐÔÄÜÏëÏó £¬Öع¹²Ù¿Ø¼«ÏÞ £¬Öع¹ÓÎÏ·Ö±²¥ÌåÑé £¬Öع¹¿Æ¼¼ÃÀѧÉè¼Æ £¬ÈÃÕâ´úоƬÊͷųöÏÂÒ»´úµÄÐÔÄÜ¡£ÊÇÎÒÃÇÀú¾­7Äê̽Ë÷ £¬·ºÆð¸ø¼«ÖÂÍæ¼ÒµÄËÄ·ÝÍêÃÀ´ð¾í¡£¡±Ëû˵¡£

¡¶ÀÈ·»Ô¼ÃÀÅ®¡·

ÍôãüÌáÐÑ £¬µ¥·½ÃæÃâÇ©Õþ²ß¡°ÀûºÃ¡± £¬µ«Ò²±£´æÈÈÞ°µãÔ¤Ô¼ÓÐÄѶÈ£»Ïû·ÑÖ§¸¶ÈÔÐèÓÅ»¯ £¬³öÐйºÎﻹ²»·ó±ã½ÝµÈÎÊÌâ¡£

¡¶Ê¯¼Òׯºó½ÖÅ®ÈË×î¶àÔÚÄĶù¡·

δÀ´ 3¨C5 Äê £¬ÖØµã¹Ø×¢¼à¹ÜÓë¹¤ÒµÑØÆ½Ì¨Ö÷ÎļþºÍ¸ö°¸ÊÊÅäÑݽø £¬ÏȶԱ༭Æ÷ÓëµÝËÍÔØÌ彨Á¢¿É¸´ÓõķÇÁÙ´²Óë CMC ¿ò¼Ü £¬ÔÙÓÃСÐÐÁÐ/ÀºÊ½ÊÔÑéÓëÕæÊµÊÀ½çÖ¤¾ÝÀ©Õ¹ÊÊÓùæÄ£¡£FDA ½üÆÚÌá³öµÄ¡°plausible mechanism pathway£¨¿ÉÖÃÐÅ»úÖÆÂ·¾¶£©¡±ÕýÊͷųöÃ÷È·Ðźţºµ±Ëæ»ú±ÈÕÕ²»¿ÉÐÐʱ £¬¼à¹Ü¿ÉÄܸüÇ¿µ÷»úÖÆ¿É½âÊÍÐÔÓë¿ÉÊÓ²ìµÄÁÙ´²¸ÄÉÆ £¬Í¬Ê±ÒªÇóÉÏÊкóÁ¬ÐøÖ¤¾Ý²¹È«¡£

¡¶ÉÌÇð200ÔªÈýСʱЧÀÍ¡·

ÉÏÖ¤±¨ÖйúÖ¤È¯ÍøÑ¶£¨¼ÇÕßµËÕ꣩1ÔÂ18ÈÕ £¬ÔÚÖ£ÖݾÙÐеġ°È˹¤ÖÇÄÜ+¡±ÓëÊý×Ö¾­¼ÃÖªÃûÉÏÊй«Ë¾ÆóÒµ¼ÒºÓÄÏÐÐÔ˶¯ÉÏ £¬»ªÔƿعɶ­Ê³¤ÑÕÏþ±õ½éÉÜÁ˹«Ë¾Ö÷ÓªÒµÎñ £¬²¢±í´ïÁËÔÚÖ£Öݼ°ºÓÄÏѰÇóÏàÖúµÄÒâÏò¡£ÑÕÏþ±õÌåÏÖ £¬»ªÔƵÄÒµÎñÖ÷Òª¼¯ÖÐÔÚÁ½´ó°å¿é£ºÒ»ÊÇÒÔ¿Í»§Ð§ÀÍ×÷ÒµÖÐÐÄΪ½¹µãµÄ¹¤ÒµÁ´£»¶þÊÇͶ×Ê¡£

ÍøÕ¾µØÍ¼